In this clip, Dr. Roland Griffiths discusses the potential uses, challenges, and risks associated with gaining FDA approval for psilocybin use as a therapeutic treatment.
In this clip, Dr. Valter Longo describes the IGF-1 pathway and explains how defects in the pathway influence disease risk.
In this clip, Dr. Roland Griffiths describes the current state of research on long-term meditation and the role psilocybin plays in that research.
In this clip, Dr. Roland Griffiths discusses the reorganizational effects that psychedelic experiences have on the brain and their potential use in treating mental disorders.
In this clip, Dr. Roland Griffiths and Dr. Rhonda Patrick discuss the sociocultural aspects of hallucinogenic substance use.
In this clip, Dr. Roland Griffiths and Dr. Rhonda Patrick discuss the effects of meditation on gene expression.
In this clip, Dr. Roland Griffiths discusses similarities in the effects of psilocybin and meditation on the brain and their potential usefulness in treating depression.
In this clip, Dr. Rhonda Patrick describes how sauna use activates the Salvinorin A pathway, potentially ameliorating symptoms of depression and opioid addiction.
In this clip, Dr. Roland Griffiths describes new findings that suggest psilocybin may be useful in managing the symptoms of treatment-resistant depression.
Dr. Valter Longo defines the different fasting modalities, and compares and contrasts the variations of each in duration and degree of restrictiveness.
Dr. Valter Longo explains how certain macronutrients influence the insulin/IGF-1/growth hormone axis to modulate aging in many cell types.
Dr. Valter Longo discusses how the fasting-mimicking diet nourishes patients while still activating some of the same metabolic responses as a water-only fast.
Dr. Valter Longo describes how fasting and the ketogenic diet used together with the standard of care treatment may help treat aggressive cancers.
Dr. Valter Longo explains why clinical trials of the fasting-mimicking diet in combination with standard cancer treatments have been slow to progress.
Dr. Longo describes the promising research that suggests that one's risk for diseases over the next 10 years may be drastically reduced.
